(Q43054611)

English

Phase 1 study of AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, in combination with chemotherapy in adults with advanced solid tumors

scientific article published on 25 May 2010

Statements

Phase 1 study of AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, in combination with chemotherapy in adults with advanced solid tumors (English)
Chris H Takimoto
Kamalesh Sankhala
John Sarantopoulos
Manuel Valdivieso
Patricia LoRusso

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit